Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020104
Filing Date
2021-04-22
Accepted
2021-04-22 16:05:29
Documents
3
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A hrtx-def14a_20210617.htm DEF 14A 2416005
2 GRAPHIC gefljzkin44b000002.jpg GRAPHIC 44964
3 GRAPHIC gefljzkin44b000001.jpg GRAPHIC 57860
  Complete submission text file 0001564590-21-020104.txt   2559108
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 21844804
SIC: 2834 Pharmaceutical Preparations